ask
stand
back
describ
broad
term
view
common
cold
probabl
frequent
acut
human
diseas
longlast
scientif
problem
particular
recent
work
antivir
abl
two
reason
like
everyon
els
suffer
cold
addit
studi
problem
virolog
clinic
point
view
year
last
common
cold
unit
salisburi
result
may
problem
perspect
possibl
give
person
view
time
describ
someth
everi
possibl
angl
quit
imposs
comprehens
done
best
reader
make
judgement
correct
soon
start
research
learnt
difficult
might
detect
new
cold
viru
earli
laboratori
rockefel
institut
new
york
found
make
roller
tube
tissu
cultur
would
support
growth
influenza
virus
took
cultur
inocul
wash
patient
cold
day
cytopath
effect
appear
excit
discov
shortli
afterward
cultur
low
grade
infect
cytotox
bacterium
discard
experi
got
work
due
cours
return
uk
appoint
staff
medic
research
council
mrc
work
sheffield
respiratori
virus
adenovirus
infuenza
circumst
led
join
work
polioviru
vaccin
role
recent
cultiv
enterovirus
seem
take
respiratori
virus
ask
work
common
cold
unit
salisburi
one
way
meant
outlook
much
narrow
anoth
broaden
greatli
possibl
approach
could
prepar
pool
filter
nasal
wash
individu
infect
clinic
materi
thu
document
stock
virus
could
propag
laboratori
could
also
use
volunt
specif
sensit
test
presenc
common
cold
viru
thu
systemat
test
growth
virus
tissu
cultur
inocul
cultur
medium
nasal
drop
group
volunt
live
isol
observ
whether
develop
cold
come
pass
common
cold
unit
realli
good
idea
one
cold
minor
respiratori
catarrh
ill
must
occur
centuri
mention
diari
literatur
late
centuri
rise
bacteriolog
cold
activ
investig
newli
develop
method
inde
took
volum
page
summar
publish
investig
viru
theori
dismiss
nine
thomson
thomson
result
report
seem
bizarr
day
possibl
guess
obtain
instanc
seem
worker
distinguish
clearli
earli
acut
ill
subsequ
catarrh
sinus
secondari
bacteri
infect
cours
good
method
avail
cultur
character
common
organ
pneumococci
haemophilu
speci
streptococcu
haemolyticu
much
confus
organ
neisseria
would
call
branhamella
anaerob
bacteriolog
also
begin
gramneg
filterpass
anaerob
alleg
exist
result
wealth
possibl
caus
organ
cultur
even
realis
bacteria
might
harmless
symbiont
possibl
convinc
oneself
certain
organ
appear
pharynx
frequent
cold
good
health
one
studi
tackl
problem
realli
care
bacteri
assess
care
imparti
experiment
design
collect
clinic
record
bacteri
specimen
mill
et
al
conclud
although
anaerob
bacteria
came
went
airway
heterogen
group
presenc
relat
time
quantiti
occurr
cold
symptom
easi
look
back
studi
confid
engend
view
retrospectoscop
see
clearli
decis
observ
howev
context
time
one
imagin
much
author
might
influenc
confus
whether
filtrat
transmit
cold
meant
power
evid
also
collect
time
show
haemolyt
streptococci
associ
pharyng
mani
complic
certain
serotyp
pneumococci
unquestion
link
pneumonia
less
ten
year
sinc
live
similar
brief
period
confus
claim
counterclaim
hiv
viru
cultur
relationship
aid
document
fact
specif
evid
virus
caus
cold
obtain
long
appropri
method
time
kruse
publish
munich
medic
weekli
result
experi
pass
nasal
wash
bacteriatight
filter
inocul
volunt
observ
cold
result
overlook
possibl
part
outbreak
war
also
discredit
volunt
isol
given
uninfect
materi
nevertheless
develop
cold
also
question
whether
filtrat
seitz
filter
berkefield
candl
would
remov
bacteria
need
care
check
ensur
hold
back
bacteria
could
done
control
test
inde
may
test
properli
done
interpret
believ
mani
anaerob
organ
could
exist
filter
form
view
best
attempt
resolv
confus
situat
made
dochez
group
rockefel
institut
dochez
et
al
care
filter
nasal
secret
check
bacteriafre
show
produc
cold
given
chimpanze
human
be
held
strict
isol
shown
prevent
cold
uninocul
subject
howev
problem
lay
ahead
shown
cold
realli
could
due
virus
group
set
cultur
viru
use
technolog
day
name
cultur
chop
chick
embryo
tissu
held
layer
paraffin
dochez
et
al
believ
could
produc
cold
materi
ch
andrew
person
commun
tri
repeat
experi
england
even
brought
cultur
new
york
ship
fail
get
convinc
data
conclud
result
due
irrit
produc
autolys
tissu
howev
studi
viral
natur
cold
well
design
execut
although
immedi
convinc
field
stood
test
time
repetit
caus
edific
studi
bacteri
caus
cold
weaken
eventu
crumbl
would
interest
piec
social
histor
research
defin
thought
belief
social
background
led
found
common
cold
unit
salisburi
uk
know
unansw
scientif
question
ch
andrew
alreadi
known
pass
human
influenza
viru
ferret
smith
et
al
anxiou
experi
cold
use
human
volunt
similar
way
furthermor
old
american
red
crossharvard
hospit
site
lain
vacant
sinc
us
armi
left
empti
move
patholog
laboratori
pari
virologist
uk
countri
desper
econom
problem
rebuild
million
damag
home
repair
reequip
factori
gener
develop
effect
peacetim
economi
yet
time
gener
hope
better
countri
better
life
postwar
year
perhap
also
believ
task
simpler
realli
month
year
research
would
reveal
common
cold
viru
vaccin
would
made
andrew
wartim
experi
also
given
rise
belief
socal
minor
infect
could
significantli
reduc
product
perceiv
would
import
peacetim
whatev
truth
may
joint
plan
formul
earli
ministri
health
would
support
accommod
volunt
two
week
medic
research
council
would
fund
laboratori
work
staff
ministri
work
would
look
build
basic
servic
matter
month
build
convert
small
staff
assembl
juli
year
first
group
seven
student
volunt
arriv
subject
first
seri
trial
continu
without
break
year
involv
almost
visit
unit
individu
one
ask
certain
question
realli
good
idea
worth
would
research
gone
equal
well
without
question
mani
way
unanswer
alway
import
clear
away
unsound
research
report
start
new
field
may
distanc
valu
adequ
earli
work
done
without
much
public
show
cold
viru
could
induc
chill
could
transmit
anim
cat
passag
success
embryon
egg
claim
previou
worker
andrew
first
care
experi
show
passag
viru
cultur
human
embryo
lung
use
ender
colleagu
first
experi
poliovirus
andrew
et
al
viru
grown
known
rhinoviru
type
call
common
cold
viru
cours
rhinoviru
grown
away
unit
appli
respiratori
specimen
techniqu
develop
ender
ie
roller
tube
cultur
monkey
kidney
cell
cultur
observ
cytopath
effect
price
pelon
et
al
howev
guess
develop
gener
method
use
tissu
cultur
later
organ
cultur
cell
gener
faster
logic
unit
abl
combin
use
new
cultur
techniqu
inocul
volunt
indic
coldproduc
agent
grow
even
limit
extent
first
found
method
propag
mani
differ
cold
actual
rhino
virus
roller
tube
cultur
human
embryo
kidney
cell
two
passag
without
cytopath
effect
cpe
medium
modifi
first
allow
serial
passag
develop
interfer
allow
rapid
cpe
occur
tyrrel
parson
hitchcock
tyrrel
other
later
found
conveni
suscept
cell
fulli
develop
method
could
use
laboratori
biolog
drug
sensit
virus
could
studi
anywher
presenc
clinic
materi
relationship
diseas
either
volunt
commun
could
determin
furthermor
old
empir
idea
exist
common
cold
viru
soon
replac
data
collect
epidemiolog
control
field
studi
infect
detect
rang
virus
follow
pathogen
confirm
studi
inocul
volunt
observ
effect
studi
prove
typic
cold
could
produc
wide
rang
virus
includ
enterovirus
paramyxovirus
certain
virus
name
rhinovirus
coronavirus
main
caus
cold
thu
could
use
laboratori
reagent
search
specif
antivir
treatment
thu
year
frustrat
work
unit
develop
point
relev
human
infect
could
produc
precis
document
clinic
laboratori
method
ideal
set
preliminari
trial
efficaci
antivir
drug
vaccin
without
nowaday
would
rare
justifi
go
field
studi
natur
acquir
cold
time
went
unit
also
play
role
provid
continu
focu
work
subject
spread
pathogenesi
cold
antivir
treatment
went
fashion
instanc
earli
experi
use
interferon
prophylaxi
cold
face
variou
problem
even
small
amount
human
interferon
sutton
tyrrel
could
show
vitro
would
render
human
cell
resist
wide
rang
virus
capabl
caus
cold
gener
view
treatment
would
never
protect
respiratori
epitheli
cell
defend
mucociliari
apparatu
furthermor
first
interferon
prepar
low
potenc
later
chemic
synthes
antivir
also
disappoint
interferon
experi
continu
purer
potent
prepar
idea
antivirai
treatment
cold
final
came
age
rhinovirusinduc
cold
prevent
unit
spray
human
leucocyt
interferon
intranas
merigan
et
al
result
confirm
shown
due
interferon
cold
prevent
leucocyt
interferon
purifi
mean
monoclon
antibodi
scott
et
al
synthes
e
coli
recombin
dna
technolog
scott
et
al
work
expand
group
earli
trial
review
scott
tyrrel
continu
exist
least
test
site
world
encourag
research
continu
antivir
eventu
chemic
synthes
molecul
detect
also
clearcut
benefici
effect
cold
develop
drug
doubt
studi
commun
interferon
common
view
time
work
pass
special
expertis
resourc
need
high
technolog
requir
provid
advanc
cours
import
ensur
research
cold
infect
exploit
contribut
best
current
laboratori
equip
electron
microscopi
molecular
biolog
method
greatli
increas
power
scienc
abl
answer
crucial
question
whether
new
molecul
provid
benefit
human
appli
absenc
anim
model
face
multipl
caus
virus
import
halfway
hous
test
tube
studi
natur
cold
identifi
promis
drug
find
use
clinic
bear
reed
import
element
willing
public
help
place
like
come
experi
invis
relationship
built
experiment
team
essenti
reproduc
success
experi
sort
done
futur
advanc
detect
virus
antibodi
also
use
studi
aspect
respiratori
infect
man
possibl
use
volunt
resourc
studi
measur
pathogen
immunogen
man
influenza
virus
modifi
variou
way
exampl
serial
passag
egg
mice
reassort
epidem
strain
view
develop
live
attenu
vaccin
work
complement
done
usa
ussr
continu
recent
year
includ
detail
molecular
analysi
candid
virus
bear
nicholson
et
al
oxford
et
al
also
possibl
document
way
virus
damag
cilia
slow
mucociliari
transport
wilson
et
al
look
role
atopi
possibl
mediat
produc
respiratori
symptom
callow
et
al
document
local
physiolog
paramet
nasal
blood
flow
bend
et
al
psycholog
factor
person
stress
also
found
import
possibl
use
volunt
cold
mild
defin
organ
diseas
one
could
document
quit
rigor
totman
et
al
cohen
et
al
effect
probabl
occur
less
common
seriou
diseas
could
studi
experiment
ethic
practic
reason
experi
show
human
perform
impair
cold
influenza
eg
smith
et
al
start
made
look
role
virusinduc
humor
factor
interferon
mediat
chang
smith
et
al
find
intend
lead
new
treatment
directli
complement
work
done
elsewher
provid
fuller
understand
diseas
turn
could
open
new
form
treatment
also
provid
number
new
techniqu
neuropsycholog
perform
test
assess
system
effect
infect
document
benefit
treatment
common
cold
unit
group
studi
respiratori
virus
human
volunt
young
man
georg
g
jackson
met
dr
andrew
visit
salisburi
unit
saw
possibl
use
climat
chamber
univers
chicago
studi
possibl
effect
chill
cold
dowl
et
al
dr
hf
dowl
other
publish
result
studi
mani
hundr
volunt
dowl
et
al
unfortun
unabl
isol
volunt
thu
work
ident
virus
studi
entir
clear
though
pioneer
work
factor
influenc
suscept
effect
amantadin
topic
great
deal
excel
laboratori
work
done
nih
bethesda
md
detect
new
virus
respiratori
diseas
childhood
instanc
parainfluenza
virus
chanock
colleagu
although
like
circumst
caus
diseas
affect
patient
found
desir
tri
fulfil
koch
postul
show
cultur
viru
would
caus
respiratori
diseas
man
thu
led
inocul
adult
room
isol
show
infect
develop
diseas
resembl
common
cold
rather
sever
lower
respiratori
diseas
found
children
group
also
work
rhinoviru
cold
use
volunt
import
earli
studi
role
antibodi
immun
infect
cate
et
al
anoth
group
nih
abl
exploit
technolog
develop
result
concern
biolog
warfar
gener
accur
defin
aerosol
variou
respiratori
virus
develop
equip
enabl
volunt
inhal
known
amount
see
knight
thu
could
calcul
amount
viru
deliv
aerosol
requir
initi
infect
furthermor
show
given
fine
aerosol
virus
otherwis
invad
upper
airway
caus
cold
would
invad
lower
airway
caus
lesion
lung
bronchi
group
transfer
baylor
univers
texa
perform
volunt
experi
local
prison
instanc
live
influenza
vaccin
continu
centr
volunt
work
set
univers
maryland
baltimor
group
also
work
known
virus
number
occas
perform
studi
influenza
virus
candid
antivir
drug
eg
togo
recent
year
outstand
centr
set
univers
virginia
charlottesvil
j
gwaltney
fg
hayden
group
particular
interest
rhinovirus
studi
field
also
set
arrang
use
interv
local
resourc
motel
conduct
studi
volunt
rigor
isol
studi
clinic
virolog
also
high
reput
work
antivir
treatment
studi
effect
intranas
interferon
etc
see
show
volunt
studi
possibl
transmit
rhinovirus
contamin
finger
howev
import
still
decid
see
occasion
basi
ec
dick
univers
wisconsin
also
set
volunt
experi
transmiss
cold
mention
later
work
reach
peak
significantli
reduc
late
nevertheless
great
valu
work
went
differ
centr
one
thing
number
volunt
one
centr
tend
small
though
power
calcul
done
day
use
best
score
subject
effect
sometim
modest
although
appar
signific
us
felt
much
comfort
conclus
experi
repeat
elsewher
similar
result
fact
remark
close
result
agre
time
instanc
clinic
effect
parainfluenza
virus
protect
effect
interferon
occas
hope
result
trial
candid
drug
could
repeat
work
move
other
final
exist
group
creat
sort
looselyknit
club
key
reagent
exchang
result
discuss
formal
inform
site
learn
mani
person
friendship
establish
reader
realis
common
cold
unit
set
time
nuremberg
trial
helsinki
declar
mind
public
experiment
scientist
medic
research
council
enunci
statement
studi
human
be
time
later
nevertheless
formal
review
bodi
exist
much
unit
life
howev
type
experi
done
care
consid
head
offic
addit
suggest
good
conduct
prison
servicemen
might
recruit
decid
strong
disciplin
could
consid
abl
volunt
freeli
though
leav
servicemen
could
come
basi
civilian
wish
volunt
made
first
approach
unit
respons
media
report
person
recommend
could
undu
pressur
stage
sent
fairli
full
descript
unit
purpos
natur
experi
includ
need
restrict
movement
contact
repeat
amplifi
final
came
unit
though
mani
wouldb
volunt
never
follow
initi
contact
alway
true
volunt
might
drop
trial
instanc
develop
quarantin
cold
might
stay
holiday
leav
earli
other
small
number
left
like
place
unit
polici
use
invas
procedur
even
long
seriou
discuss
final
decid
collect
blood
sampl
least
studi
furthermor
polici
administ
viru
might
produc
seriou
let
alon
possibl
lethal
diseas
thu
although
unmodifi
common
cold
virus
given
influenza
virus
alway
passag
order
attenu
thu
gener
principl
volunt
give
true
free
inform
consent
nonhazard
experi
accept
appli
encod
ethic
committe
rule
procedur
spite
care
approach
experi
done
would
accept
today
extens
use
made
human
embryo
tissu
obtain
patient
clinic
histori
evid
infect
handl
clean
area
howev
test
bacteri
fungal
infect
administr
volunt
furthermor
occas
viru
propag
monkey
kidney
cell
use
although
cultur
test
haemadsorb
cytopath
agent
know
noncytopath
organ
test
local
ethic
committe
introduc
abl
compli
requir
difficulti
occas
extra
paperwork
rememb
height
controversi
human
guinea
pig
public
debat
pit
abl
determin
ladi
took
line
experi
human
be
uneth
unsaf
end
hour
summar
view
probabl
dr
tyrrel
alright
still
think
look
back
one
see
precaut
incomplet
due
lack
knowledg
time
guidelin
follow
conduct
studi
sound
close
enunci
recent
report
royal
colleg
physician
common
hold
like
infecti
diseas
might
brought
control
interven
number
way
prevent
transmiss
enhanc
host
immun
limit
viru
replic
prevent
unwant
effect
host
ie
symptom
sign
nose
elsewher
tri
one
way
anoth
follow
brief
comment
summar
current
view
tri
describ
think
may
lead
theoret
practic
earli
day
mode
transmiss
guess
text
book
medicin
said
cold
transmit
talk
sneez
cough
work
unit
elsewher
suggest
cold
transmit
children
volunt
airborn
rout
lovelock
et
al
techniqu
avail
detect
viru
air
quantit
viru
mixtur
droplet
eject
air
sneez
howev
nose
collect
particl
air
inspir
rate
litr
per
minut
nevertheless
transmiss
infect
rel
infrequ
eg
hendley
et
al
infect
initi
inhal
one
infecti
unit
clear
low
concentr
unit
air
would
suffici
explain
epidemiolog
find
volunt
studi
coxsackieviru
shown
cold
could
transmit
one
end
long
room
air
contact
possibl
couch
et
al
demonstr
coxsacki
viru
like
rhinoviru
shed
drop
droplet
air
subject
cold
similar
droplet
infect
nose
effici
inhal
buckland
et
al
howev
littl
viru
saliva
littl
becam
airborn
talk
hendley
colleagu
univers
virginia
report
viru
could
get
onto
skin
fomit
patient
cold
hendley
et
al
knew
viru
could
infect
place
onto
nasal
mucosa
contamin
swab
finger
byno
et
al
buckland
et
al
thu
transmiss
indirect
contact
would
possibl
howev
realli
difficult
question
often
happen
rather
rel
import
transmiss
contact
airborn
rout
quantit
studi
seem
us
show
finger
rout
rel
ineffici
reed
recent
care
experiment
work
manual
transmiss
group
play
poker
prevent
use
splint
larg
plastic
collar
yet
rhinoviru
infect
freeli
transmit
airborn
rout
must
major
import
circumst
dick
et
al
nevertheless
earlier
experi
show
viricid
tissu
prevent
transmiss
experiment
poker
game
dick
et
al
howev
order
test
whether
finger
transmiss
import
famili
gwaltney
group
set
placebocontrol
household
studi
block
transmiss
rhinoviru
cold
finger
turn
difficult
experi
conduct
although
trend
favour
treat
group
larg
statist
signific
overal
effect
farr
et
al
earli
work
use
uv
light
school
classroom
show
transmiss
measl
could
slow
imped
airborn
transmiss
neither
use
viricid
tissu
seem
practic
method
prevent
substanti
amount
transmiss
water
treatment
food
hygien
profound
effect
water
foodborn
diseas
seem
unlik
anyth
success
develop
respiratori
viru
infect
nevertheless
good
ventil
hand
hygien
encourag
like
good
host
resist
soon
first
rhinovirus
cultur
collabor
set
produc
inactiv
vaccin
given
intramuscularli
volunt
came
unit
prove
resist
cold
produc
intranas
challeng
live
viru
serotyp
scientif
committe
although
other
believ
secretori
antibodi
particular
import
done
recent
studi
show
circul
antibodi
stimul
vaccin
longlast
protect
significantli
ill
although
secretori
antibodi
effect
prevent
infect
rossen
et
al
barclay
et
al
sequenc
structur
rhinovirus
becom
better
known
possibl
identifi
possibl
linear
peptid
epitop
viru
surfac
turn
suggest
possibl
search
peptid
could
given
kill
vaccin
produc
neutralis
antibodi
franci
et
al
cours
mani
difficulti
along
way
antigen
need
tcell
epitop
variabl
human
immun
respons
etc
possibl
vaccin
rhinovirus
worth
explor
inde
enter
new
era
antigen
site
two
repres
rhinovirus
type
la
map
onto
model
viru
particl
rossman
et
al
appleyard
et
al
turn
locat
edg
canyon
around
symmetri
axi
particl
determin
human
volunt
make
antibodi
least
site
rhinoviru
type
identifi
mous
monoclon
antibodi
challeng
volunt
show
presenc
antibodi
associ
resist
viru
infect
carey
et
al
mani
site
seem
conform
specif
amino
acid
may
involv
site
seen
one
monoclon
antibodi
problem
undoubtedli
complex
basic
work
need
site
edg
canyon
fulli
identifi
mimick
synthet
one
serotyp
let
alon
type
known
howev
alreadi
suggest
may
possibl
gener
neutralis
antibodi
conserv
sequenc
deeper
canyon
suspect
site
interact
viru
cell
receptor
rossman
success
appli
discoveri
interferon
alpha
beta
interferon
ifn
fl
produc
virusinfect
cell
protect
cell
come
contact
trigger
develop
state
resist
viru
infect
well
known
exogen
interferon
deliv
nasal
spray
protect
human
experiment
natur
acquir
common
cold
see
scott
tyrrel
includ
refer
group
particular
charlottesvil
howev
famili
studi
effect
rhinovirus
prolong
administr
dose
big
enough
protect
gave
rise
nasal
symptom
mild
nose
bleed
stuffi
etc
thu
interferon
use
continu
prophylaxi
found
hope
ifnfl
might
show
differ
ratio
concentr
give
protect
advers
effect
prove
ifn
gamma
ifn
also
tri
dose
equival
antivir
effect
vitro
howev
benefici
prophylact
effect
inde
seem
make
symptom
wors
higgin
et
al
possibl
enhanc
product
viru
receptor
cell
surfac
see
nevertheless
mani
interferon
other
gener
gene
manipul
synthesi
studi
laboratori
perhap
one
found
rel
less
toxic
could
use
prophylaxi
one
problem
howev
satisfactori
laboratori
test
local
inflammatori
effect
toxic
effect
limit
clinic
use
meantim
attempt
made
devis
schedul
mean
antivir
effect
would
retain
local
advers
effect
would
lost
howev
seem
dose
reduc
point
produc
nasal
symptom
also
detect
antivir
effect
monto
et
al
prophylaxi
could
use
clinic
practic
certain
condit
would
much
better
abl
improv
cours
cold
drug
administ
symptom
began
ie
therapeut
natur
recombin
interferon
test
way
experiment
influenza
rhinoviru
infect
volunt
longer
effect
possibl
subject
alreadi
produc
substanti
amount
recent
tri
cold
induc
rsv
report
rsv
infect
children
induc
endogen
interferon
case
ad
interferon
might
expect
effect
unfortun
although
ifn
given
prophylact
highli
effect
given
maximum
practic
dose
immedi
symptom
appear
confer
benefit
third
approach
enhanc
host
immun
would
use
local
administ
immunomodul
might
effect
irrespect
biolog
serolog
type
viru
might
free
local
advers
effect
interferon
recent
investig
two
one
muramyl
dipeptid
deriv
protect
mice
guinea
pig
given
small
dose
intranas
prior
larg
dose
influenza
virus
howev
given
maximum
accept
dose
volunt
improv
clinic
laboratori
paramet
experiment
influenza
even
though
strain
use
partli
attenu
dose
given
larg
thioguanosin
deriv
found
protect
mice
coronaviru
infect
enhanc
resist
rather
direct
antivir
effect
also
studi
volunt
use
cold
induc
coronaviru
analysi
indic
either
given
low
dose
enhanc
primat
respons
way
rodent
higgin
et
al
field
similar
stage
work
interferon
know
attract
theoret
possibl
know
whether
method
made
work
man
benchmark
properti
candid
drug
express
belief
possibl
antivir
treatment
cold
test
varieti
antirhinoviru
molecul
deriv
independ
screen
programm
exampl
wellcom
foundat
dichloroflavan
nippon
roch
antivir
chalcon
turn
inactiv
viru
infect
bind
particl
stabil
particl
effect
low
ph
heat
drug
potent
test
vitro
dichloroflavan
dissolv
oil
prodrug
chalcon
develop
well
absorb
given
mouth
unfortun
activ
volunt
challeng
sensit
rhinoviru
appar
enter
nasal
secret
still
inact
formul
intranas
spray
et
al
b
furthermor
drug
rhonepoulenc
relat
mode
action
watersolubl
effect
either
go
substanti
programm
research
antipicornaviru
drug
sterl
winthrop
group
start
discoveri
effect
arildon
enteroviru
infect
led
discoveri
disoxaril
mani
congen
particularli
import
smith
et
al
studi
crystal
rhinoviru
soak
disoxaril
show
bound
viru
capsid
pocket
base
canyon
round
axi
viru
symmetri
region
probabl
involv
viru
entri
uncoat
janssen
foundat
also
look
antirhinoviru
drug
evalu
mani
molecul
one
develop
possibl
drug
lpiperazinyl
pyrazidin
andri
et
al
drug
also
bound
suscept
rhinovirus
inactiv
stabil
studi
drugresist
mutant
show
extens
crossresist
includ
dichloroflavan
disoxaril
indic
site
action
abovement
drug
near
sterl
winthrop
molecul
dearden
et
al
prove
effect
rhinoviru
type
volunt
given
prophylact
intranas
spray
seri
trial
suggest
number
interest
conclus
barrow
et
al
unlik
interferon
appear
pretreat
import
one
discontinu
treatment
earli
symptom
return
treatment
began
infect
symptom
appear
effect
treatment
began
symptom
appear
benefici
effect
hint
volunt
given
treatment
cold
control
recov
ie
six
day
might
subsequ
develop
cold
treatment
withdrawn
ie
drug
suppress
rather
cur
studi
volunt
given
short
cours
treatment
viru
shed
appar
prolong
drug
resist
virus
could
recov
particularli
drug
withdrawn
dearden
et
al
thu
type
antivir
treatment
quit
differ
characterist
say
intranas
interferon
acyclovir
herp
viru
much
research
need
one
thing
molecul
differ
activ
differ
serotyp
viru
test
volunt
maximum
activ
vitro
serotyp
anoth
thing
treatment
regim
must
tri
order
avoid
return
symptom
appear
drugresist
virus
molecul
differ
antivir
spectra
synthes
investig
might
use
combin
order
produc
prepar
activ
full
rang
serotyp
might
possibl
exploit
synerg
differ
molecul
detect
vitro
area
see
real
possibl
design
drug
drug
combin
ahmad
tyrrel
known
relationship
serotyp
rhinoviru
molecular
structur
drug
inactiv
inde
one
think
molecul
probe
hydrophob
interior
viru
particl
monoclon
antibodi
probe
surfac
group
rossmann
purdu
univers
defin
site
bind
viru
capsid
find
similar
site
use
disoxarih
may
make
possibl
improv
chemic
structur
reason
choic
rather
trial
error
chapman
et
al
rhinovirus
variabl
antigen
appear
also
vari
consider
sensit
potent
antivir
drug
howev
known
fall
two
group
judg
abil
infect
cell
tissu
cultur
name
infect
human
cell
h
strain
major
receptor
group
infect
monkey
human
cell
strain
minor
receptor
group
sever
group
tri
identifi
receptor
molecul
involv
viru
entri
respons
specif
receptor
molecul
major
group
identifi
purifi
tomassini
colonno
recent
clone
sequenc
three
group
identifi
intercellular
adhes
moleculel
eg
staunton
et
al
previous
known
surfac
compon
mani
cell
includ
endothelium
involv
interact
lymphocyt
express
respons
variou
cytokin
includ
ifnt
antibodi
inhibit
viru
growth
thu
antibodi
molecul
bind
viru
solubl
might
use
prevent
treat
infect
major
receptor
group
rhinovirus
doubt
vigor
research
find
use
product
type
also
correspond
blocker
minor
receptor
group
infect
common
practic
refer
wide
use
folk
otc
remedi
cold
symptomat
mean
pejor
howev
seem
unfair
would
ideal
treat
infect
attack
infecti
agent
would
practic
commenc
treatment
symptom
sign
develop
treatment
might
prevent
viru
lead
widespread
diseas
uncommon
nasal
symptom
subsid
gradual
even
infect
stop
track
therefor
arguabl
case
infect
like
coronaviru
rhinoviru
cold
normal
quickli
selflimit
best
approach
would
reliev
patient
discomfort
disabl
leav
immun
system
take
care
viru
furthermor
case
viral
bacteri
infect
gastrointestin
tract
lead
diarrhoea
best
handl
manag
physiolog
effect
usual
oral
rehydr
immun
system
control
infect
troubl
know
rel
littl
way
nose
respond
infect
therefor
use
rough
measur
control
symptom
eg
administ
gener
adrenerg
stimul
revers
vasodil
nasal
mucosa
know
howev
antihistamin
prevent
specif
symptom
hay
fever
allerg
rhiniti
histamin
key
mediat
pathogen
chain
diseas
equal
precis
inform
cold
rather
low
amount
leukotrin
prostaglandin
histamin
found
nasal
secret
cold
callow
et
al
block
cholinerg
transmiss
limit
effect
cold
symptom
gaffey
et
al
hand
inhibitor
mast
cell
degranul
imped
mediat
releas
benefici
effect
cold
even
though
prove
due
effect
mediat
barrow
et
al
import
studi
care
object
menthol
long
use
reliev
symptom
nasal
obstruct
appar
block
sensori
pathway
nose
leav
patenc
airway
unchang
method
avail
measur
blood
flow
mucos
temperatur
well
patenc
nasal
secret
occasion
use
document
effect
viru
infect
nose
bend
et
al
anticip
benefit
treatment
howev
recent
shown
bradykinin
induc
symptom
nasal
irrit
discharg
found
rais
concentr
nasal
secret
individu
rhinoviru
cold
naclerio
et
al
proud
et
al
antikinin
develop
reason
investig
whether
reliev
symptom
sign
cold
initi
studi
one
candid
npc
unsuccess
higgin
et
al
attract
approach
problem
specif
hypothes
specif
probe
also
worth
explor
less
welldefin
approach
modifi
host
respons
area
recent
studi
shown
steroid
treatment
delay
clinic
respons
experiment
cold
farr
et
al
local
hyperthermia
inhal
watersatur
air
immedi
effect
improv
symptom
also
lesser
effect
last
day
would
interest
determin
chang
glucocorticoid
heat
induc
nasal
mucosa
tri
identifi
associ
reduc
symptom
possibl
stress
nasal
cell
hyperthermia
turn
socal
heat
shock
protein
modifi
tissu
respons
infect
earli
day
unit
thought
antivir
treatment
intrins
imposs
other
would
impract
limit
use
instanc
would
need
given
prophylact
would
given
intranas
nevertheless
interest
member
first
group
drug
shown
effect
respiratori
virus
man
name
amantadin
successor
activ
given
therapeut
mouth
seem
advantag
pharrnacokinet
wellabsorb
secret
activ
respiratori
tract
eg
et
al
hand
particlebind
antirhinoviru
drug
hydrophob
probabl
reason
effect
may
also
explain
secret
mucu
result
molecul
given
local
schedul
drug
administr
quit
demand
order
keep
drug
concentr
high
enough
induc
longlast
chang
like
antivir
state
produc
interferon
attach
cell
indic
antirhinoviru
drug
better
pharmacokinet
drug
distribut
properti
might
satisfactori
clinic
even
though
better
molecul
yet
avail
might
still
possibl
improv
perform
improv
formul
fact
retrospect
studi
dichloroflavan
roch
chalcon
directli
compar
although
dosag
regim
challeng
viru
method
observ
drug
formul
differ
way
particular
janssen
drug
formul
cyclodextran
distinctli
probabl
significantli
differ
use
earlier
studi
probabl
individu
molecul
drug
locat
hydrophob
interior
extern
hydrophil
molecul
thu
nearli
aqueou
solut
solut
oil
micron
suspens
drug
method
drug
present
develop
instanc
incorpor
small
sphere
polym
provid
delay
releas
bioadhes
properti
type
formul
made
possibl
give
insulin
intranas
rat
obtain
suffici
absorpt
signific
metabol
effect
essay
focuss
mainli
rhinovirus
main
caus
common
cold
howev
know
coronavirus
well
paramyxovirus
enterovirus
also
make
small
signific
contribut
substanti
fraction
due
yet
unidentifi
organ
larson
et
al
mean
even
highli
effect
specif
rhinoviru
treatment
develop
would
provid
benefit
mani
cold
nevertheless
human
coronavirus
explor
molecular
level
infect
one
serotyp
alreadi
diagnos
use
nucleic
acid
probe
myint
et
al
reason
keep
option
open
prepar
studi
antimedi
treatment
mention
also
illunderstood
empir
treatment
local
zinc
treatment
nasal
hyperthermia
present
origin
antivir
treatment
former
administ
oral
lozeng
seem
produc
symptomat
benefit
effect
viru
infect
studi
unit
good
studi
done
elsewher
use
slightli
differ
viru
experiment
design
show
benefit
local
hyperthermia
air
rel
humid
origin
suggest
way
inhibit
replic
rhinovirus
studi
volunt
inhibit
detect
studi
gener
practic
seem
produc
symptomat
improv
mention
probabl
much
hope
antivir
attack
virus
programm
search
anticoronaviru
drug
might
well
worth
undertak
search
might
becom
ration
past
perhap
specif
bind
site
might
found
essenti
viru
protein
done
rhinovirus
molecular
techniqu
use
rhinoviru
detect
oligonucleotid
probe
conserv
region
noncod
region
amplif
polymeras
chain
reaction
pcr
gama
et
al
antibodi
follow
sensit
specif
use
elisa
eg
barclay
et
al
host
respons
also
assess
clinic
physiolog
method
test
human
perform
enabl
us
assess
system
effect
infect
benefit
treatment
smith
et
al
technolog
enhanc
detail
clinic
studi
drug
effect
document
unless
effect
anim
model
develop
belief
experi
human
volunt
continu
play
key
part
develop
specif
antivir
therapi
essay
expand
talk
frankli
person
assess
recent
research
work
done
unit
antivir
common
cold
afraid
neither
complet
histori
common
cold
research
volunt
full
review
result
recent
work
antirhinoviru
drug
certainli
literari
panach
one
modern
bioessayist
hope
read
assess
gener
view
elicit
job
biologist
regard
fortun
paid
spend
work
life
fascin
area
research
seen
drastic
transform
understand
virus
diseas
possibl
treatment
bonu
byproduct
made
mani
good
friend
around
world
